Page b1 bof b822
Test Bank for Basic and Clinical Pharmacology
b b b b b b
14th Edition by Bertram G. Katzung
b b b b b b b
Chapters 1 - 66 Complete
b b b b
, Page b2 bof b822
Table of Contents
b b
1. bIntroduction: bThe bNature bof bDrugs b& bDrug bDevelopment b& bRegulation
2. bDrug bReceptors b& bPharmacodynamics
3. bPharmacokinetics b& bPharmacodynamics: bRational bDosing b& bthe bTime bCourse bof bDrug bAction
4. bDrug bBiotransformation
5. bPharmacogenomics
6. bIntroduction bto bAutonomic bPharmacology
7. bCholinoceptor-Activating b& bCholinesterase-Inhibiting bDrugs
8. bCholinoceptor-Blocking bDrugs
9. bAdrenoceptor bAgonists b& bSympathomimetic bDrugs
10. bAdrenoceptor bAntagonist bDrugs
11. bAntihypertensive bAgents
12. bVasodilators b& bthe bTreatment bof bAngina bPectoris
13. bDrugs bUsed bin bHeart bFailure
14. bAgents bUsed bin bCardiac bArrhythmias
15. bDiuretic bAgents
16. bHistamine, bSerotonin, b& bthe bErgot bAlkaloids
17. bVasoactive bPeptides
18. bThe bEicosanoids: bProstaglandins, bThromboxanes, bLeukotrienes, b& bRelated bCompounds
19. bNitric bOxide
20. bDrugs bUsed bin bAsthma
21. bIntroduction bto bthe bPharmacology bof bCNS bDrugs
22. bSedative-Hypnotic bDrugs
23. bThe bAlcohols
24. bAntiseizure bDrugs
25. bGeneral bAnesthetics
26. bLocal bAnesthetics
27. bSkeletal bMuscle bRelaxants
28. bPharmacologic bManagement bof bParkinsonism b& bOther bMovement bDisorders
29. bAntipsychotic bAgents b& bLithium
30. bAntidepressant bAgents
31. bOpioid bAgonists b& bAntagonists
32. bDrugs bof bAbuse
33. bAgents bUsed bin bCytopenias; bHematopoietic bGrowth bFactors
34. bDrugs bUsed bin bDisorders bof bCoagulation
35. bAgents bUsed bin bDyslipidemia
36. bNonsteroidal bAnti-Inflammatory bDrugs, bDisease-Modifying bAntirheumatic bDrugs, bNonopioid
bAnalgesics, b& bDrugs bUsed bin bGout
37. bHypothalamic b& bPituitary bHormones
38. bThyroid b& bAntithyroid bDrugs
, Page b3 bof b822
39. bAdrenocorticosteroids b& bAdrenocortical bAntagonists
40. bThe bGonadal bHormones b& bInhibitors
41. bPancreatic bHormones b& bAntidiabetic bDrugs
42. bAgents bThat bAffect bBone bMineral bHomeostasis
43. bBeta-Lactam b& bOther bCell bWall- b& bMembrane-Active bAntibiotics
44. bTetracyclines, bMacrolides, bClindamycin, bChloramphenicol, bStreptogramins, b& bOxazolidinones
45. bAminoglycosides b& bSpectinomycin
46. bSulfonamides, bTrimethoprim, b& bQuinolones
47. bAntimycobacterial bDrugs
48. bAntifungal bAgents
49. bAntiviral bAgents
50. bMiscellaneous bAntimicrobial bAgents; bDisinfectants, bAntiseptics, b& bSterilants
51. bClinical bUse bof bAntimicrobial bAgents
52. bAntiprotozoal bDrugs
53. bClinical bPharmacology bof bthe bAntihelminthic bDrugs
54. bCancer bChemotherapy
55. bImmunopharmacology
56. bIntroduction bto bToxicology: bOccupational b& bEnvironmental
57. bHeavy bMetal bIntoxication b& bChelators
58. bManagement bof bthe bPoisoned bPatient
59. bSpecial bAspects bof bPerinatal b& bPediatric bPharmacology
60. bSpecial bAspects bof bGeriatric bPharmacology
61. bDermatologic bPharmacology
62. bDrugs bUsed bin bthe bTreatment bof bGastrointestinal bDiseases
63. bTherapeutic b& bToxic bPotential bof bOver-the-Counter bAgents
64. bDietary bSupplements b& bHerbal bMedications
65. bRational bPrescribing b& bPrescription bWriting
66. bImportant bDrug bInteractions b& bTheir bMechanisms b
, Page b4 bof b822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
b b b b b b b b b b b
1. A bnurse bworking bin bradiology badministers biodine bto ba bpatient bwho bis
bhaving ba bcomputed btomography b(CT) bscan. bThe bnurse bworking bon bthe
boncology bunit badministers bchemotherapy bto bpatients bwho bhave bcancer. bAt
bthe bPublic bHealth bDepartment, ba bnurse badministers ba bmeasles-mumps-
rubella b(MMR) bvaccine btoba b14-month-old bchild bas ba broutine
bimmunization. bWhich bbranch bof bpharmacology bbest bdescribes bthe bactions
bof ball bthree b nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology bis bthe bstudy bof bthe bbiologic beffects bof bchemicals. bNurses
bare binvolved bwith bclinical bpharmacology bor bpharmacotherapeutics, bwhich
bis ba bbranch bof bpharmacology bthat bdeals bwith bthe buses bof bdrugs bto btreat,
bprevent, band bdiagnose bdisease. bThe bradiology bnurse bis badministering ba
bdrug bto bhelp bdiagnose ba bdisease. bThe boncology bnurse bis badministering ba
bdrug bto bhelp btreat bab
disease. bPharmacoeconomics bincludes bany bcosts
binvolved bin bdrug b therapy.
Pharmacodynamics binvolves bhow ba bdrug baffects bthe bbody
bandb pharmacokinetics bis bhow bthe bbody bacts bon bthe bbody.
2. A bphysician bhas bordered bintramuscular b(IM) binjections bof bmorphine, ba
bnarcotic, bevery b4 bhours bas bneeded bfor bpain bin ba bmotor bvehicle baccident
bvictim.b
The bnurse bis baware bthis bdrug bhas ba bhigh babuse bpotential. bUnder
bwhat bcategorybwould bmorphine bbe bclassified?
A) Schedule bI
B) Schedule bII
Test Bank for Basic and Clinical Pharmacology
b b b b b b
14th Edition by Bertram G. Katzung
b b b b b b b
Chapters 1 - 66 Complete
b b b b
, Page b2 bof b822
Table of Contents
b b
1. bIntroduction: bThe bNature bof bDrugs b& bDrug bDevelopment b& bRegulation
2. bDrug bReceptors b& bPharmacodynamics
3. bPharmacokinetics b& bPharmacodynamics: bRational bDosing b& bthe bTime bCourse bof bDrug bAction
4. bDrug bBiotransformation
5. bPharmacogenomics
6. bIntroduction bto bAutonomic bPharmacology
7. bCholinoceptor-Activating b& bCholinesterase-Inhibiting bDrugs
8. bCholinoceptor-Blocking bDrugs
9. bAdrenoceptor bAgonists b& bSympathomimetic bDrugs
10. bAdrenoceptor bAntagonist bDrugs
11. bAntihypertensive bAgents
12. bVasodilators b& bthe bTreatment bof bAngina bPectoris
13. bDrugs bUsed bin bHeart bFailure
14. bAgents bUsed bin bCardiac bArrhythmias
15. bDiuretic bAgents
16. bHistamine, bSerotonin, b& bthe bErgot bAlkaloids
17. bVasoactive bPeptides
18. bThe bEicosanoids: bProstaglandins, bThromboxanes, bLeukotrienes, b& bRelated bCompounds
19. bNitric bOxide
20. bDrugs bUsed bin bAsthma
21. bIntroduction bto bthe bPharmacology bof bCNS bDrugs
22. bSedative-Hypnotic bDrugs
23. bThe bAlcohols
24. bAntiseizure bDrugs
25. bGeneral bAnesthetics
26. bLocal bAnesthetics
27. bSkeletal bMuscle bRelaxants
28. bPharmacologic bManagement bof bParkinsonism b& bOther bMovement bDisorders
29. bAntipsychotic bAgents b& bLithium
30. bAntidepressant bAgents
31. bOpioid bAgonists b& bAntagonists
32. bDrugs bof bAbuse
33. bAgents bUsed bin bCytopenias; bHematopoietic bGrowth bFactors
34. bDrugs bUsed bin bDisorders bof bCoagulation
35. bAgents bUsed bin bDyslipidemia
36. bNonsteroidal bAnti-Inflammatory bDrugs, bDisease-Modifying bAntirheumatic bDrugs, bNonopioid
bAnalgesics, b& bDrugs bUsed bin bGout
37. bHypothalamic b& bPituitary bHormones
38. bThyroid b& bAntithyroid bDrugs
, Page b3 bof b822
39. bAdrenocorticosteroids b& bAdrenocortical bAntagonists
40. bThe bGonadal bHormones b& bInhibitors
41. bPancreatic bHormones b& bAntidiabetic bDrugs
42. bAgents bThat bAffect bBone bMineral bHomeostasis
43. bBeta-Lactam b& bOther bCell bWall- b& bMembrane-Active bAntibiotics
44. bTetracyclines, bMacrolides, bClindamycin, bChloramphenicol, bStreptogramins, b& bOxazolidinones
45. bAminoglycosides b& bSpectinomycin
46. bSulfonamides, bTrimethoprim, b& bQuinolones
47. bAntimycobacterial bDrugs
48. bAntifungal bAgents
49. bAntiviral bAgents
50. bMiscellaneous bAntimicrobial bAgents; bDisinfectants, bAntiseptics, b& bSterilants
51. bClinical bUse bof bAntimicrobial bAgents
52. bAntiprotozoal bDrugs
53. bClinical bPharmacology bof bthe bAntihelminthic bDrugs
54. bCancer bChemotherapy
55. bImmunopharmacology
56. bIntroduction bto bToxicology: bOccupational b& bEnvironmental
57. bHeavy bMetal bIntoxication b& bChelators
58. bManagement bof bthe bPoisoned bPatient
59. bSpecial bAspects bof bPerinatal b& bPediatric bPharmacology
60. bSpecial bAspects bof bGeriatric bPharmacology
61. bDermatologic bPharmacology
62. bDrugs bUsed bin bthe bTreatment bof bGastrointestinal bDiseases
63. bTherapeutic b& bToxic bPotential bof bOver-the-Counter bAgents
64. bDietary bSupplements b& bHerbal bMedications
65. bRational bPrescribing b& bPrescription bWriting
66. bImportant bDrug bInteractions b& bTheir bMechanisms b
, Page b4 bof b822
Chapter 1. Introduction: The Nature of Drugs & Drug Development & Regulation
b b b b b b b b b b b
1. A bnurse bworking bin bradiology badministers biodine bto ba bpatient bwho bis
bhaving ba bcomputed btomography b(CT) bscan. bThe bnurse bworking bon bthe
boncology bunit badministers bchemotherapy bto bpatients bwho bhave bcancer. bAt
bthe bPublic bHealth bDepartment, ba bnurse badministers ba bmeasles-mumps-
rubella b(MMR) bvaccine btoba b14-month-old bchild bas ba broutine
bimmunization. bWhich bbranch bof bpharmacology bbest bdescribes bthe bactions
bof ball bthree b nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
ANSWER: B
Feedback:
Pharmacology bis bthe bstudy bof bthe bbiologic beffects bof bchemicals. bNurses
bare binvolved bwith bclinical bpharmacology bor bpharmacotherapeutics, bwhich
bis ba bbranch bof bpharmacology bthat bdeals bwith bthe buses bof bdrugs bto btreat,
bprevent, band bdiagnose bdisease. bThe bradiology bnurse bis badministering ba
bdrug bto bhelp bdiagnose ba bdisease. bThe boncology bnurse bis badministering ba
bdrug bto bhelp btreat bab
disease. bPharmacoeconomics bincludes bany bcosts
binvolved bin bdrug b therapy.
Pharmacodynamics binvolves bhow ba bdrug baffects bthe bbody
bandb pharmacokinetics bis bhow bthe bbody bacts bon bthe bbody.
2. A bphysician bhas bordered bintramuscular b(IM) binjections bof bmorphine, ba
bnarcotic, bevery b4 bhours bas bneeded bfor bpain bin ba bmotor bvehicle baccident
bvictim.b
The bnurse bis baware bthis bdrug bhas ba bhigh babuse bpotential. bUnder
bwhat bcategorybwould bmorphine bbe bclassified?
A) Schedule bI
B) Schedule bII
